WGS - GeneDx Holdings Corp.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$96.43
DETAILS
HIGH:
$150.00
LOW:
$70.00
MEDIAN:
$85.00
CONSENSUS:
$96.43
UPSIDE:
103.83%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 427.5 | 305.4 | 202.6 | 234.7 | 212.2 | 179.3 | 196.2 |
| Cost of Revenue | 129.4 | 111.1 | 112.6 | 261.4 | 228.8 | 175.3 | 113.4 |
| Gross Profit | 298.2 | 194.4 | 90.0 | (26.8) | (16.6) | 4.0 | 82.8 |
| Operating Expenses | |||||||
| R&D Expenses | 72.0 | 45.7 | 58.3 | 86.2 | 105.2 | 72.7 | 34.9 |
| SG&A Expenses | 239.2 | 168.5 | 194.7 | 338.2 | 318.7 | 163.9 | 68.8 |
| Other Expenses | 0 | 3.4 | 17.6 | 216.5 | 5.7 | 9.4 | 9.5 |
| Operating Expenses | 311.2 | 217.6 | 270.6 | 640.9 | 429.5 | 246.0 | 113.2 |
| Operating Income | |||||||
| Operating Income | (11.8) | (23.2) | (180.6) | (667.7) | (446.1) | (242.0) | (30.4) |
| Interest Expense | 2.5 | 3.0 | 0 | 3.2 | 2.8 | 2.5 | 0.8 |
| Interest Income | 0 | 0 | 1.1 | 2.5 | 0.1 | 0.5 | 1.0 |
| Profitability | |||||||
| EBITDA | 6.6 | (1.3) | (136.5) | (398.2) | (220.7) | (227.1) | (22.5) |
| EBIT | (18.6) | (23.2) | (170.2) | (457.5) | (242.6) | (238.9) | (28.9) |
| Income Before Tax | (21.1) | (52.6) | (176.7) | (598.0) | (245.4) | (241.3) | (29.7) |
| Income Tax Expense | (0.1) | (0.3) | (0.9) | (49.1) | 0 | 0 | 0 |
| Net Income | (21.0) | (52.3) | (175.8) | (549.0) | (245.4) | (241.3) | (29.7) |
| Per Share Data | |||||||
| EPS (Basic) | -0.73 | -1.94 | -7.23 | -53.63 | -74.93 | -33.16 | -4.26 |
| EPS (Diluted) | -0.73 | -1.94 | -7.23 | -53.63 | -74.93 | -146.94 | -18.48 |
| Shares Outstanding | 26.9 | 26.9 | 24.3 | 10.2 | 3.3 | 5.6 | 5.6 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Current Assets | ||||||
| Cash & Cash Equivalents | 105.0 | 85.2 | 99.7 | 137.4 | 400.6 | 108.1 |
| Short-Term Investments | 66.3 | 56.0 | 30.5 | 0 | 0 | 0 |
| Net Receivables | 74.4 | 37.6 | 32.8 | 43.3 | 26.6 | 32.3 |
| Inventory | 14.0 | 10.7 | 8.8 | 13.7 | 33.5 | 25.0 |
| Other Current Assets | 1.5 | 1.1 | 2.0 | 6.4 | 3.8 | 4.1 |
| Total Current Assets | 268.3 | 198.0 | 182.3 | 212.6 | 483.5 | 174.1 |
| Non-Current Assets | ||||||
| Property, Plant & Equipment | 69.1 | 58.5 | 59.4 | 84.3 | 62.7 | 63.1 |
| Goodwill | 13.5 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 168.5 | 158.6 | 172.6 | 186.7 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0.9 | 0.9 | 10.8 |
| Other Non-Current Assets | 3.3 | 4.3 | 4.4 | 6.5 | 6.9 | 3.6 |
| Total Non-Current Assets | 301.9 | 221.4 | 236.4 | 332.6 | 70.5 | 77.5 |
| Total Assets | 570.2 | 419.4 | 418.8 | 545.3 | 554.1 | 251.6 |
| Current Liabilities | ||||||
| Account Payables | 2.5 | 8.0 | 10.2 | 46.0 | 44.7 | 26.7 |
| Short-Term Debt | 8.9 | 0 | 0.5 | 10.9 | 3.4 | 3.5 |
| Deferred Revenue | 0 | 0 | 0 | 0.0 | 0.5 | 1.8 |
| Other Current Liabilities | 67.9 | 30.4 | 30.9 | 67.1 | 52.7 | 41.4 |
| Total Current Liabilities | 108.9 | 54.8 | 58.8 | 144.3 | 101.3 | 73.4 |
| Non-Current Liabilities | ||||||
| Long-Term Debt | 87.0 | 51.9 | 52.7 | 6.2 | 11 | 19.0 |
| Deferred Tax Liabilities | 47.2 | 1.0 | 1.6 | 57.0 | 0 | 0 |
| Other Non-Current Liabilities | (37.1) | 5.5 | 14.7 | 24.0 | 35.3 | 134.1 |
| Total Non-Current Liabilities | 153.1 | 119.3 | 131.9 | 147.3 | 64.7 | 173.8 |
| Total Liabilities | 262.0 | 174.1 | 190.7 | 291.6 | 166.0 | 247.3 |
| Stockholders' Equity | ||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 |
| Retained Earnings | (1,373.5) | (1,352.5) | (1,300.2) | (1,124.4) | (575.4) | (330.1) |
| Accumulated Other Comprehensive Income | 0.9 | 0.8 | 0.4 | 0 | 0 | 0 |
| Total Stockholders' Equity | 308.2 | 245.2 | 228.0 | 253.7 | 388.1 | 4.4 |
| Total Liabilities & Equity | 570.2 | 419.4 | 418.8 | 545.3 | 554.1 | 251.6 |
| Debt Metrics | ||||||
| Total Debt | 151.9 | 116.2 | 119.8 | 77.1 | 32.8 | 43.3 |
| Net Debt | 46.9 | 31.0 | 20.1 | (60.3) | (367.7) | (64.9) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (21.0) | (52.3) | (175.8) | (549.0) | (245.4) | (241.3) | (29.7) |
| Depreciation & Amortization | 25.2 | 22.0 | 35.8 | 59.3 | 21.8 | 11.7 | 6.4 |
| Stock-Based Compensation | 32.2 | 9.1 | (0.3) | 42.0 | 219.4 | 120.2 | 5.5 |
| Change in Working Capital | (15.6) | (24.7) | (38.2) | 36.1 | 8.1 | 13.8 | (0.7) |
| Other Non-Cash Items | 12.5 | 17.8 | (0.7) | 141.5 | (194.3) | 2.4 | (0.2) |
| Operating Cash Flow | 33.3 | (28.5) | (180.1) | (319.2) | (190.4) | (93.1) | (18.7) |
| Investing Activities | |||||||
| Capital Expenditure | (19.0) | (5.5) | (5.7) | (14.3) | (20.8) | (32.0) | (15.5) |
| Acquisitions | (32.9) | 0 | (8.1) | (127.0) | 0 | 0 | 0 |
| Purchases of Investments | (55.7) | (66.3) | (47.7) | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 46.0 | 41.7 | 17.8 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | (11.4) | (7.9) | 0 |
| Investing Cash Flow | (61.5) | (30.1) | (43.7) | (141.3) | (20.8) | (32.0) | (15.5) |
| Financing Activities | |||||||
| Net Debt Issuance | (3.7) | (3.2) | 43.0 | (3.3) | (13.5) | 11.7 | (1.7) |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0.9 | 0.3 | 2.9 | 64.5 | 0 | 30.9 |
| Financing Cash Flow | 48.0 | 44.2 | 186.2 | 197.3 | 493.7 | 129.1 | 148.0 |
| Cash Position | |||||||
| Net Change in Cash | 19.8 | (14.5) | (37.7) | (263.2) | 282.5 | 4.0 | 113.8 |
| Cash at Beginning | 86.2 | 100.7 | 137.4 | 401.5 | 119.0 | 115.0 | 1.2 |
| Cash at End | 106.0 | 86.2 | 99.7 | 138.3 | 401.5 | 119.0 | 115.0 |
| Free Cash Flow | 14.3 | (34.0) | (185.9) | (333.5) | (211.2) | (125.1) | (34.2) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 427.5 | 305.4 | 202.6 | 234.7 | 212.2 | 179.3 | 196.2 |
| Gross Profit | 298.2 | 194.4 | 90.0 | (26.8) | (16.6) | 4.0 | 82.8 |
| Operating Income | (11.8) | (23.2) | (180.6) | (667.7) | (446.1) | (242.0) | (30.4) |
| Net Income | (21.0) | (52.3) | (175.8) | (549.0) | (245.4) | (241.3) | (29.7) |
| EPS (Diluted) | -0.73 | -1.94 | -7.23 | -53.63 | -74.93 | -146.94 | -18.48 |
| Balance Sheet | |||||||
| Cash & Equivalents | 105.0 | 85.2 | 99.7 | 137.4 | 400.6 | 108.1 | |
| Total Assets | 570.2 | 419.4 | 418.8 | 545.3 | 554.1 | 251.6 | |
| Total Debt | 151.9 | 116.2 | 119.8 | 77.1 | 32.8 | 43.3 | |
| Stockholders' Equity | 308.2 | 245.2 | 228.0 | 253.7 | 388.1 | 4.4 | |
| Cash Flow | |||||||
| Operating Cash Flow | 33.3 | (28.5) | (180.1) | (319.2) | (190.4) | (93.1) | (18.7) |
| Capital Expenditure | (19.0) | (5.5) | (5.7) | (14.3) | (20.8) | (32.0) | (15.5) |
| Free Cash Flow | 14.3 | (34.0) | (185.9) | (333.5) | (211.2) | (125.1) | (34.2) |